HIV drug resistance webinar: Report on the Global Action Plan on HIV Drug Resistance 2017-2021 and a future integrated Global Action Plan to prevent, monitor, and respond to drug-resistant HIV, viral hepatitis and sexually transmitted infections.
Background
In 2017, WHO published a five-year Global Action Plan (GAP) on HIV drug resistance (HIVDR) to address the public health impact of drug-resistant HIV. The GAP on HIVDR outlined a framework and interventions for countries and global stakeholders to prevent, monitor and respond to the emergence of drug-resistant HIV. The GAP timeframe concluded in 2021, and a Report on the GAP 2017-2021 has been published.
This webinar reviewed the impact of the GAP on HIVDR 2017-2021. It presented WHO’s plan to develop an integrated GAP linking drug resistance prevention, monitoring, and response activities at all levels for HIV, viral hepatitis and sexually transmitted infections.
Objectives
- to provide a high-level overview Report on the Global Action Plan (GAP) on HIV Drug resistance 2017-2021;
- to provide a detailed overview of the successes and challenges as reported in the Report on the GAP 2017-2021 and potential future directions as they relate to HIV drug resistance prevention and response, HIV drug resistance monitoring and surveillance, HIV drug resistance research priorities, laboratory capacity for viral load and HIVDR testing in low- and middle-income countries, and governance, financing and enabling mechanisms; and
- to update the global audience on WHO’s plans for an integrated Global Action Plan on drug resistance for HIV, viral hepatitis, and priority STIs 2024–2030.
Date
Monday, 20 November 2023, 13:00-14:35 CET.
Language
The webinar was held in English.